Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patients. Huang Y, Xu C, Sun Y, Wang W, et al. Lung Cancer 2022;172:117-123.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang Y, Xu C, Sun Y, Wang W, et al. Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patients. Lung Cancer 2022;172:117-123.
PMID: 36063602